188 related articles for article (PubMed ID: 3258871)
1. Immunocytochemical study of the cellular immune response in meningiomas.
Rossi ML; Cruz Sanchez F; Hughes JT; Esiri MM; Coakham HB
J Clin Pathol; 1988 Mar; 41(3):314-9. PubMed ID: 3258871
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of mononuclear cells in meningiomas.
Bø L; Mørk SJ; Nyland H
Neuropathol Appl Neurobiol; 1992 Dec; 18(6):548-58. PubMed ID: 1488087
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study on HLA-DR expression in human meningiomas.
Ohara N; Hayashi K; Miyake K; Jeon HJ; Takahashi K; Akagi T
Acta Neuropathol; 1992; 84(1):110-2. PubMed ID: 1380199
[TBL] [Abstract][Full Text] [Related]
4. The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.
Fang L; Lowther DE; Meizlish ML; Anderson RC; Bruce JN; Devine L; Huttner AJ; Kleinstein SH; Lee JY; Stern JN; Yaari G; Lovato L; Cronk KM; O'Connor KC
Neuro Oncol; 2013 Nov; 15(11):1479-90. PubMed ID: 23978377
[TBL] [Abstract][Full Text] [Related]
5. Expression of beta2 integrins and macrophage-associated antigens in meningeal tumours.
Mosnier JF; Perret AG; Scoazec JY; Brunon J
Virchows Arch; 2000 Feb; 436(2):131-7. PubMed ID: 10755603
[TBL] [Abstract][Full Text] [Related]
6. Tumor infiltrating immune cells in gliomas and meningiomas.
Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological investigation of mononuclear cell infiltrates in meningiomas.
Becker I; Roggendorf W
Acta Neuropathol; 1989; 79(2):211-6. PubMed ID: 2596270
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody analysis of major histocompatibility complex expression in human meningiomas.
Becker I; Roggendorf W
J Neuroimmunol; 1989 Dec; 25(2-3):161-7. PubMed ID: 2584394
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
[TBL] [Abstract][Full Text] [Related]
10. Immunological and vascular characteristics in cavernous sinus meningioma.
Kosugi K; Tamura R; Ohara K; Morimoto Y; Kuranari Y; Oishi Y; Yoshida K; Toda M
J Clin Neurosci; 2019 Sep; 67():198-203. PubMed ID: 31213381
[TBL] [Abstract][Full Text] [Related]
11. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
13. [Changes in immune status indicators in patients with supratentorial meningiomas].
Kislitsyn IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(11):26-8. PubMed ID: 10578531
[TBL] [Abstract][Full Text] [Related]
14. Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.
Tirakotai W; Mennel HD; Celik I; Hellwig D; Bertalanffy H; Riegel T
Neurosurg Rev; 2006 Jan; 29(1):41-8. PubMed ID: 16010579
[TBL] [Abstract][Full Text] [Related]
15. Characterization of immune cell infiltration into canine intracranial meningiomas.
Boozer LB; Davis TW; Borst LB; Zseltvay KM; Olby NJ; Mariani CL
Vet Pathol; 2012 Sep; 49(5):784-95. PubMed ID: 21987303
[TBL] [Abstract][Full Text] [Related]
16. Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T
Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783
[TBL] [Abstract][Full Text] [Related]
17. Growth factor (M-CSF) and antigenic properties of macrophages in meningioma.
Giometto B; Bozza F; Gallo P; Pagni S; Argentiero V; Ferla S; Mingrino S; Tavolato B
J Neurooncol; 1992 May; 13(1):25-33. PubMed ID: 1377230
[TBL] [Abstract][Full Text] [Related]
18. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
Rutland JW; Gill CM; Loewenstern J; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Shrivastava RK; Fowkes M
Cancer Immunol Immunother; 2021 Jan; 70(1):169-176. PubMed ID: 32661686
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the immune status of patients with brain tumors in the pre- and postoperative periods].
Lisianyĭ NI; Romodanov SA; Trosh RM; Rudenko VA; Radzievskiĭ AA
Zh Vopr Neirokhir Im N N Burdenko; 1991; (4):19-21. PubMed ID: 1659076
[TBL] [Abstract][Full Text] [Related]
20. Landscape of immune cell gene expression is unique in predominantly WHO grade 1 skull base meningiomas when compared to convexity.
Zador Z; Landry AP; Balas M; Cusimano MD
Sci Rep; 2020 Jun; 10(1):9065. PubMed ID: 32493984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
